Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
Cantor Fitzgerald
Argus Health
Farmers Insurance
Chinese Patent Office

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 091322

« Back to Dashboard

NDA 091322 describes MEFENAMIC ACID, which is a drug marketed by Breckenridge Pharm, Lupin Ltd, Vintage Pharms Llc, and Viva Hlthcare, and is included in four NDAs. It is available from four suppliers. Additional details are available on the MEFENAMIC ACID profile page.

The generic ingredient in MEFENAMIC ACID is mefenamic acid. There are thirteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
Summary for 091322
Applicant:Lupin Ltd
Ingredient:mefenamic acid
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 091322
Medical Subject Heading (MeSH) Categories for 091322
Suppliers and Packaging for NDA: 091322
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEFENAMIC ACID mefenamic acid CAPSULE;ORAL 091322 ANDA Lupin Pharmaceuticals, Inc. 68180-185 68180-185-13 3 BLISTER PACK in 1 CARTON (68180-185-13) > 8 CAPSULE in 1 BLISTER PACK (68180-185-11)
MEFENAMIC ACID mefenamic acid CAPSULE;ORAL 091322 ANDA Lupin Pharmaceuticals, Inc. 68180-185 68180-185-01 100 CAPSULE in 1 BOTTLE (68180-185-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength250MG
Approval Date:Jul 22, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chinese Patent Office
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.